Gladstone investigator wins MIND Prize to decode hidden Alzheimer’s genetics

Gladstone Institutes investigator Ryan Corces, PhD, has been named a 2026 winner of the Pershing Square Foundation's MIND Prize, a prestigious award recognizing next-frontier thinkers who are uncovering a deeper understanding of the brain and cognition.

The prize, issued annually to eight scientists, seeks to catalyze high-impact neuroscience research by facilitating collaborations across academic, biomedical industry, philanthropic, and business communities.

The 2026 Prize winners each receive $750,000 over three years to support breakthroughs in research on neurodegenerative diseases, including Alzheimer's disease and other aging-related dementias, which affect millions of people worldwide.

"Thanks to advanced technologies and human creativity, Alzheimer's disease and her siblings are finally being considered remediable disorders of the human condition," says Pershing Square Foundation Trustee Neri Oxman, PhD, in announcing this year's award winners. "This year's cohort reflects the promise of technological and biological research serendipity, tying molecular structures with behavioral patterns and genetic predispositions with the power of AI (artificial intelligence)."